Axsome Therapeutics Inc AXSM:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 08/12/22 EDT
45.53quote price arrow down-0.74 (-1.60%)
Volume
17,685
Close
46.27quote price arrow up+0.95 (+2.10%)
Volume
585,089
52 week range
19.38 - 48.82
Loading...
  • Open45.63
  • Day High47.12
  • Day Low45.12
  • Prev Close45.32
  • 52 Week High48.82
  • 52 Week High Date08/11/22
  • 52 Week Low19.38
  • 52 Week Low Date08/19/21

Key Stats

  • Market Cap1.865B
  • Shares Out40.30M
  • 10 Day Average Volume0.91M
  • Dividend-
  • Dividend Yield-
  • Beta1.91
  • YTD % Change22.47

KEY STATS

  • Open45.63
  • Day High47.12
  • Day Low45.12
  • Prev Close45.32
  • 52 Week High48.82
  • 52 Week High Date08/11/22
  • 52 Week Low19.38
  • 52 Week Low Date08/19/21
  • Market Cap1.865B
  • Shares Out40.30M
  • 10 Day Average Volume0.91M
  • Dividend-
  • Dividend Yield-
  • Beta1.91
  • YTD % Change22.47

RATIOS/PROFITABILITY

  • EPS (TTM)-3.92
  • P/E (TTM)-11.80
  • Fwd P/E (NTM)-12.11
  • EBITDA (TTM)-142.397M
  • ROE (TTM)-346.11%
  • Revenue (TTM)8.82M
  • Gross Margin (TTM)88.86%
  • Net Margin (TTM)-1,699.92%
  • Debt To Equity (MRQ)614.88%

EVENTS

  • Earnings Date11/07/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO4:1504:15
The economy has fallen into the technical definition of a recession, says Kevin Mahn

Profile

MORE
Axsome Therapeutics, Inc. is a biopharmaceutical company. The Company is developing novel therapies for central nervous system (CNS) disorders for which there are limited treatment options. It is developing products that meaningfully improve the lives of patients and provide new therapeutic options for physicians. The Company's CNS portfolio includes four product candidates, such as AXS-05, AXS-07, AXS-12, and AXS-14. AXS-05 is being developed for the treatment of major...
Herriot Tabuteau M.D.
Chairman of the Board, President, Chief Executive Officer, Founder
Mark Jacobson
Chief Operating Officer
Nick Pizzie CPA
Chief Financial Officer
Hunter Murdock Esq.
Executive Vice President - Legal and Compliance
Lori Englebert
Executive Vice President - Commercial and Business Development
Address
22 Cortlandt Street, 16Th Floor
New York, NY
10007
United States

Top Peers

SYMBOLLASTCHG%CHG
CLDX
Celldex Therapeutics Inc
37.33+2.80+8.11%
RXRX
Recursion Pharmaceuticals Inc
12.04+0.83+7.40%
IBRX
Immunitybio Inc
4.52+0.10+2.26%
AGIO
Agios Pharmaceuticals Inc
28.15+2.16+8.31%
SWTX
SpringWorks Therapeutics Inc
29.19+0.93+3.29%